Chemical and analytical characterization of related organic impurities in drugs

Analytical and Bioanalytical Chemistry

Volumn 377, Issue 5, 2003, Pages 852-862

  Görög, Sándor ^a  

^a GEDEON RICHTER LTD   (Hungary)

Author keywords

Cimetidine; Enalapril maleate; Ethynodiol diacetate; Ethynylsteroids; Hydrocortisone; Impurity profiling; Lisinopril; Pipecuronium bromide; Prednisolone

Indexed keywords

ALCOHOLS; BIOSYNTHESIS; BYPRODUCTS; CARBOXYLIC ACIDS; CHARACTERIZATION; DRUG PRODUCTS; MOLECULAR STRUCTURE;

CIMETIDINE ETHYNYLSTEROIDS; ENALAPRIL MALEATE; ETHYNODIOL DIACETATE; HYDROCORTISONE; IMPURITY PROFILING; LISINOPRIL; PIPECURONIUM BROMIDE; PREDNISOLONE;

IMPURITIES;

CIMETIDINE; DRUG; ENALAPRIL; ETYNODIOL DIACETATE; HYDROCORTISONE; LISINOPRIL; NORETHISTERONE; NORGESTREL; ORGANIC COMPOUND; PIPECURONIUM; PREDNISOLONE;

CHEMISTRY; DRUG CONTAMINATION; ISOLATION AND PURIFICATION; REVIEW;

CIMETIDINE; DRUG CONTAMINATION; ENALAPRIL; ETHYNODIOL DIACETATE; HYDROCORTISONE; LISINOPRIL; NORETHINDRONE; NORGESTREL; ORGANIC CHEMICALS; PHARMACEUTICAL PREPARATIONS; PIPECURONIUM; PREDNISOLONE;

EID: 1542787788     PISSN: 16182642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00216-003-2140-6     Document Type: Review

References (72)

1. Görög S (2003) Trends Anal Chem 22:407-415
2. Ahuja S (1998) Impurities evaluation of pharmaceuticals. Marcel Dekker, New York
3. Görög S (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, p 715
4. Görög S (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 72-73
5. Gazdag M (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 223-227
6. Görög S (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, p 12
7. Görög S, Crommen J, Gergely A, Tárkányi G (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 525-574
8. Görög S (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 473-524
9. Ferenczi-Fodor K, Végh Z (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 148-182
10. Gazdag M (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 210-239
11. Laukó A (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 183-209
12. Gyllenhall O (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 382-395
13. Altria K (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 323-345
14. Euerby MR (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 346-358
15. Mák M, Brlik J, Czira G (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 97-108
16. Szántay Cs Jr, Demeter Á (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 109-145
17. Görög S (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 84-96, 252-265
18. Laukó A (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 191-193
19. Tollsten L (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 266-298
20. Lane SL (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 359-381
21. Aranyi A (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 240-251
22. Wilson ID, Griffiths L, Lindon JC, Nicholson JK (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 299-322
23. Lee R (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 23-37
24. Bertram J (2000) In: Görög S (ed) Identification and determination of impurities in drugs. Elsevier, Amsterdam, pp 409-438
25. ICH Topic Q3A (R) (1999) Impurities in new drug substances. The European Agency for the Evaluation of Medicinal Products, London
26. Szepesi G. Görög S (1974) Analyst 99:218-221
27. Görög S, Szász Gy (1978) Analysis of Steroid Hormone Drugs. Elsevier, Amsterdam, p 148
28. European Pharmacopoeia, 4th edn (2003) Council of Europe, Strasbourg
29. Lukács F, Péter A, Sipos-Nagy G, Burger K, Low M, Schon I, Kisfaludy L (1989) Inorg Chim Acta 157:121-126
30. Görög S, Halmos Zs, Herényi B, Georgakis A, Balogh G, Csizér É, Tuba Z (1990) In: Görög S (ed) Advances in steroid analysis '90. Akadémiai Kiadó, Budapest, pp 323-329
31. Szepesi G, Gazdag M, Mihályfi K (1989) J Chromatogr 464: 265-278
32. Gazdag M, Babják M, Kemenes-Bakos P, Görög S (1991) J Chromatogr 550:639-644
33. Görög S, Balogh G, Gazdag M (1991) J Pharm Biomed Anal 9: 829-833
34. Görög S. Herényi B, Rényei M (1992) J Pharm Biomed Anal 10:831-835
35. Halmos Zs, Szántay Cs Ir, Brlik J, Csehi A, Varga K, Horváth P, Kislaki M, Domány Gy, Nemes A, Görög S (1996) J Pharm Biomed Anal 15:1-5
36. Horváth P, Balogh G, Brlik J, Csehi A, Dravecz F, Halmos Zs, Laukó A, Rényei M, Varga K, Görög S (1997) J Pharm Biomed Anal 16:1343-1349
37. Görög S, Babják M, Balogh G, Brlik J. Dravecz F, Gazdag M, Horváth P, Laukó A, Varga K (1998) J Pharm Biomed Anal 18: 511-525
38. Gazdag M, Mihályfi K, Görög S (1997) Anal Chim Acta 352: 231-237
39. Gazdag M, Mihályfi K, Kemenes-Bakos P, Görög S (1997) Acta Pharm Hung 67:169-174
40. Görög S, Laukó A, Herényi B, Czira G, Csizér É, Tuba Z (1979) Acta Chim Hung 100:377-382
41. Babják M, Balogh G, Gazdag M, Görög S (2002) J Pharm Biomed Anal 29:1153-1157
42. Görög S, Herényi B (1987) J Chromatogr 400:177-186
43. Laukó A, Csehi A, Balogh G, Csizér É, Herényi B, Görög S (1991) Acta Pharm Hung 98-103
44. Görög S, Brlik J, Csehi A, Halmos Zs, Herényi B, Horváth P, Dravecz F, Bor D (1995) Anal Methods Instrum 2:154-157
45. Görög S, Laukó A, Herényi B (1988) J Pharm Biomed Anal 6:697-705
46. Görög S, Babják M, Balogh G, Brlik J, Csehi A, Dravecz F, Gazdag M, Horváth P, Laukó A, Varga K (1997) Talanta 44: 1517-1526
47. Balogh G, Csizér É, Ferenczy Gy G, Halmos Zs, Herényi B, Horváth P, Laukó A, Görög S (1995) Pharm Res 12:295-298
48. Wünsch E, Jaeger E, Kisfaludy L, Low M (1977) Angew Chem 16:317-318
49. Görög S, Laukó A, Herényi B, Georgakis A, Csizér É, Balogh G, Gálik Gy, Mahó S, Tuba Z (1988) Chromatographia 26: 316-320
50. Li M, Ahuja ES, Watkins DM (2003) J Pharm Biomed Anal 31: 29-38
51. Görög S (1989) Steroid analysis in the pharmaceutical industry. Ellis Horwood, Chichester, p 197
52. Görög S, Balogh G, Csehi A, Csizér É, Gazdag M, Halmos Zs, Hegedus B, Herényi B, Horváth P, Laukó A (1993) J Pharm Biomed Anal 11:1219-1226
53. Laukó A, Görög S (1976) J Chromatogr 118:409-410
54. The United States Pharmacopoeia 26 (2003) USP Convention Ine, Rockville
55. Szántay Cs Jr, Bihari M, Brlik J, Csehi A, Kassai A, Aranyi A (1994) Acta Pharm Hung 64:105-108
56. Cvak L, Jegorov P, Sedmera P, Havlicek V, Ondracek J, Husak M, Pakhomova S, Kratochvil B, Granzin J (1994) J Chem Soc Perkin Trans 2:1861-1865
57. Laukó A, Csizér É, Görög S (1993) Analyst 118:609-611
58. Görög S, Herényi B (1978) J Chromatogr 152:240-242
59. Görög S, Herényi B, Nyéki O, Schon I, Kisfaludy L (1988) J Chromatogr 452:317-321
60. Pharmeuropa(1998) 10:198
61. Gazdag M, Szepesi G, Mihályfi K (1988) J Chromatogr 450: 145-155
62. Chankvetadze B, Kartozia I, Yamamoto C, Okamoto Y, Blaschke G (2003) J Pharm Biomed Anal 30:1897-1906
63. Tárkányi G (2002) J Chromatogr A 961:257-276
64. ICH Topic Q3B (1999) Note for guidance on impurities in new drug products. The European Agency for the Evaluation of Medicinal Products, London
65. Gazdag M, Babják M, Brlik J, Mahó S, Tuba Z, Görög S (1998) J Pharm Biomed Anal 17:1029-1036
66. Görög S, Bihari M, Csizér É, Dravecz F, Gazdag M, Herényi B (1995) J Pharm Biomed Anal 14:85-92
67. Carstensen JT (1995) Drug stability, 2nd edn. Marcel Dekker, New York
68. Hjorth Tønnesen H (ed) (1995) Photostability of drugs and drug formulations. Taylor & Francis, London
69. Görög S (1995) Ultraviolet-visible spectrophotometry in pharmaceutical analysis. CRC Press, Boca Raton
70. Görög S, Rényei M, Herényi, B (1989) J Pharm Biomed Anal 7:1527-1533
71. Níessen WMA (2001) Liquid chromatography - mass spectrometry, 2nd edn. Marcel Dekker, New York, pp 405-463
72. British Pharmacopoeia (2000) The Stationery Office, London